Proton Pump Inhibitors Use in Patients With Ischemic Stroke on Dual Antiplatelet Therapy at Low Risk of Upper Gastrointestinal Bleeding.

20 , 21 Our study, which showed an increasing trend in PPI use despite the absence of clear stroke guidelines, 4 suggests that clinicians may be influenced by the potential benefits of PPI outlined in coronary guidelines. 12 , 13 , 14 , 15 Notably, our findings indicate that PPI use could decrease significant UGIB risk, even in low‐risk groups.

also in 63,971 other papers